ArticleDiabetes, metabolic syndrome and obesity : targets and therapy2026
GLP-1 Receptor Agonists Reduce Aortic Dissection and Hypertensive Crisis in Diabetic Patients with Aortic Aneurysm: A Retrospective Cohort Study.
Article in Diabetes, metabolic syndrome and obesity : targets and therapy, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Aortic aneurysm rupture and dissection carry mortality exceeding 50%, yet evidence-based medical therapies for this high-risk population remain limited. Despite mechanistic evidence suggesting glucagon-like peptide-1 receptor agonists (GLP-1RAs) stabilize vascular inflammation, no large-scale study has evaluated their impact on acute aortic events in diabetic patients with pre-existing aortic aneurysm. Methods: This retrospective active-comparator new-user cohort study utilized TriNetX data from 152 US healthcare organizations (2016-2023). A total of 11,581 adults with type 2 diabetes and documented non-ruptured aortic aneurysm initiating GLP-1RA (n=5676) or dipeptidyl peptidase-4 inhibitors (DPP-4i; n=5905) were identified. DPP-4i was selected as the active comparator given its documented cardiovascular neutrality, whereas sodium-glucose cotransporter-2 inhibitors were not used as a comparator due to their established cardiovascular benefits. After 1:1 propensity-score matching, 3857 patients per group were analyzed using Cox proportional hazards models. Results: GLP-1RA therapy was associated with lower risks of aortic rupture/dissection requiring surgical repair (hazard ratio [HR] 0.75, 95% CI 0.60-0.94; Conclusion: In diabetic patients with pre-existing aortic aneurysm, GLP-1RA therapy was associated with lower incidence of aortic rupture/dissection, hypertensive crisis, and mortality compared with DPP-4i, supporting preferential consideration of GLP-1RA in this high-risk population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.